A detailed history of Sbi Securities Co., Ltd. transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 6,077 shares of BMEA stock, worth $9,723. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,077
Previous 2,554 137.94%
Holding current value
$9,723
Previous $5.44 Million 101.08%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025

BUY
$1.37 - $2.9 $4,826 - $10,216
3,523 Added 137.94%
6,077 $10.9 Million
Q1 2025

May 01, 2025

BUY
$2.13 - $4.48 $2,130 - $4,480
1,000 Added 64.35%
2,554 $5.44 Million
Q4 2024

Feb 05, 2025

BUY
$3.88 - $12.41 $6,029 - $19,285
1,554 New
1,554 $6.03 Million

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $46.9M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Sbi Securities Co., Ltd. Portfolio

Follow Sbi Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sbi Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sbi Securities Co., Ltd. with notifications on news.